GGrantIndex
Sort

166,118 grants matching stem cells

Chromatin Structure, Epigenetic and Developmental Regulation of Mammalian Gene

$2,471,019
Ann Dean · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK

Structural and mechanistic studies of herpesvirus entry into host cells

$2,471,000
Ekaterina Heldwein · Tufts University Boston · DP2 · FY2007 · OD

Center for Genomically Engineered Organs

$2,469,443
George M Church · Harvard Medical School · RM1 · FY2015 · HG

Lentiviral Gene Therapy for Sickle Cell Disease and Immunodeficiency Disorders

$2,469,009
Brian P Sorrentino · St. Jude Children'S Research Hospital · P01 · FY2010 · HL

Foamy Viral Gene Therapy for X-linked Severe Combined Immune Deficiency

$2,468,981
David J Rawlings · Seattle Children'S Hospital · P01 · FY2015 · AI

A Foundational Resource of Functional Elements, TF footprints and Gene Regulatory Interactions

$2,468,464
Jason Daniel Buenrostro · Broad Institute, Inc. · UM1 · FY2025 · HG

Foamy Viral Gene Therapy for X-linked Severe Combined Immune Deficiency

$2,468,421
David J Rawlings · Seattle Children'S Hospital · P01 · FY2016 · AI

COG NCTN Year 9 BIQSFP Supplement & Progress Report

$2,468,151
Douglas S. Hawkins · Public Health Institute · U10 · FY2022 · CA

Dissecting the role of the dentate gyrus microcircuit to improve cognitive discrimination in aging and Alzheimer's Disease

$2,467,494
Attila Losonczy · Columbia University Health Sciences · RF1 · FY2023 · AG

Cancer Center Support Grant

$2,467,468
Thomas P Loughran · University Of Virginia · P30 · FY2015 · CA

RNA INTERFERENCE AS A WEAPON AGAINST BIOTERRORISM

$2,467,065
Immune Disease Institute, Inc. · U19 · FY2004 · AI

Rebuilding the Failing Heart

$2,467,028
Piero Anversa · Brigham And Women'S Hospital · P01 · FY2013 · HL

UCCRC--CANCER CENTER SUPPORT GRANT

$2,466,698
University Of Chicago · P30 · FY2000 · CA

GENE THERAPY FOR SICKLE CELL ANEMIA

$2,465,735
Albert Einstein Col Of Med Yeshiva Univ · P01 · FY2004 · HL

Discovery and validation of novel targets for pharmacotherapy of alcoholism

$2,465,593
Markus Heilig · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2010 · AA

Optimizing Human B and T Cell Vaccines Against HIV Using Humanized BLT Mice

$2,465,248
Todd M Allen · Massachusetts General Hospital · P01 · FY2014 · AI

Transmembrane Signaling Mechanisms

$2,464,608
Lutz Birnbaumer · National Institute Of Environmental Health Sciences · Z01 · FY2008 · ES

Neutrophil lineage in inflammation

$2,464,555
Sergio Daniel Catz · Scripps Research Institute, The · P01 · FY2023 · HL

Malaria immunology

$2,464,408
Susan Pierce · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI

Dynamics of Colonization and Infection by Multidrug-resistant Pathogens in Immunocompromised and Critically Ill Patients (DYNAMITE)

$2,463,657
Cesar Augusto Arias · University Of Texas Hlth Sci Ctr Houston · P01 · FY2020 · AI

New Approaches to Inducing Cardiac Allograft Tolerance

$2,462,802
Joren C Madsen · Massachusetts General Hospital · P01 · FY2021 · HL

Biochemistry Of Lymphocyte Activation

$2,462,667
John J. O'Shea · Arthritis, Musculoskeletal, Skin Dis · Z01 · FY2007 · AR

Systematic and scalable phenotyping of mouse mutants for neuropsychiatric disease genetics

$2,462,651
Joseph D Dougherty · Washington University · RM1 · FY2025 · MH

The Early Life Exposome and Childhood Health - The Colorado Healthy Start 3 Cohort Study

$2,462,168
Dana Dabelea · University Of Colorado Denver · UH3 · FY2022 · OD

The Early Life Exposome and Childhood Health - The Colorado Healthy Start 3 Cohort Study

$2,462,168
Dana Dabelea · University Of Colorado Denver · UH3 · FY2020 · OD